Ticagrelor(CAS: 274693-27-5)

Ticagrelor is an antiplatelet medication used to prevent blood clots. Its chemical formula is C19H18N4O4S2, and it is a white to off-white crystalline powder. It is highly soluble in DMSO and has a molecular weight of 414.48 g/mol. Ticagrelor works by inhibiting the P2Y12 receptor on platelets, thereby reducing the risk of cardiovascular events.

Ticagrelor is primarily used in the treatment of patients with acute coronary syndrome (ACS) to reduce the risk of heart attack, stroke, and death. It is also prescribed for long-term prevention of atherothrombotic events in individuals who have had a recent myocardial infarction. As a P2Y12 receptor antagonist, it plays a key role in antiplatelet therapy and is widely used in pharmaceutical research.

Ticagrelor is generally considered safe when used as directed. It is approved by regulatory authorities like the FDA and EMA for its therapeutic use. However, like all medications, it may cause side effects such as bleeding, dyspnea, or bruising. Proper handling and adherence to safety guidelines are essential to minimize risks and ensure safe administration.

Ticagrelor should be stored in a cool, dry place away from moisture and light. It is typically kept at a temperature between 15°C to 30°C (59°F to 86°F) in a sealed container. Avoid exposure to high humidity and direct sunlight to maintain its stability and efficacy over time.